Salivary LL-37 secretion in individuals with Down syndrome is normal

Journal of Dental Research

Volumn 85, Issue 10, 2006, Pages 933-936

  Bachrach, G ^a   Chaushu, G ^b   Zigmond, M ^a   Yefenof, E ^a   Stabholz, A ^a   Shapira, J ^a   Merrick, J ^c   Chaushu, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c DIVISION FOR INTELLECTUAL AND DEVELOPMENTAL DISABILITIES   (Israel)

Author keywords

Antimicrobial peptides; Down syndrome; hCAP18; Innate immunity; LL 37; Saliva

Indexed keywords

EID: 33750067402     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910608501012     Document Type: Article

References (27)

1. Andersson E, Sorensen OE, Frohm B, Borregaard N, Egesten A, Malm J (2002). Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum Reprod 17:2529-2534.
2. Bachrach G, Banai M, Bardenstein S, Hoida G, Genizi A, Bercovier H (1994). Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs. Infect Immun 62:5361-5366.
3. Barnett ML, Press KP, Friedman D, Sonnenberg EM (1986). The prevalence of periodontitis and dental caries in a Down's syndrome population. J Periodontol 57:288-293.
4. Chaushu S, Yefenof E, Becker A, Shapira J, Chaushu G (2002a). Severe impairment of secretory Ig production in parotid saliva of Down syndrome individuals. J Dent Res 81:308-312.
5. Chaushu S, Yefenof E, Becker A, Shapira J, Chaushu G (2002b). A link between parotid salivary Ig level and recurrent respiratory infections in young Down's syndrome patients. Oral Microbiol Immunol 17:172-176.
6. Cichon P, Crawford L, Grimm WD (1998). Early-onset periodontitis associated with Down's syndrome-clinical interventional study. Ann Periodontol 3:370-380.
7. Cochran WG (1977). Sampling techniques. Third ed. New York, NY: John Wiley & Sons.
8. Cowland JB, Johnsen AH, Borregaard N (1995). hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 368:173-176.
9. Cutress TW (1971). Periodontal disease and oral hygiene in trisomy 21. Arch Oral Biol 16:1345-1355.
10. Defraia E, Marinelli A (2001). Oral manifestations of congenital neutropenia or Kostmann syndrome. J Clin Pediatr Dent 26:99-102.
11. Desai SS (1997). Down syndrome: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:279-285.
12. Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, Boman A, et al. (1996). Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86-92.
13. Murakami M, Ohtake T, Dorschner RA, Gallo RL (2002). Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 81:845-850.
14. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160.
15. Orner G (1976). Periodontal disease among children with Down's syndrome and their siblings. J Dent Res 55:778-782.
16. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, et al. (2005). Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother 55:888-896.
17. Putsep K, Carlsson G, Boman HG, Andersson M (2002). Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149.
18. Reuland-Bosma W, van Dijk J (1986). Periodontal disease in Down's syndrome: a review. J Clin Periodontol 13:64-73.
19. Rozen R, Steinberg D, Bachrach G (2004). Streptococcus mutans fructosyltransferase interactions with glucans. FEMS Microbiol Lett 232:39-43.
20. Saxén L, Aula S (1982). Periodontal bone loss in patients with Down's syndrome: a follow-up study. J Periodontol 53:158-162.
21. Saxén L, Aula S, Westermarck T (1977). Periodontal disease associated with Down's syndrome: an orthopantomographic evaluation. J Periodontol 48:337-340.
22. Shaw L, Saxby MS (1986). Periodontal destruction in Down's syndrome and in juvenile periodontitis. How close a similarity? J Periodontol 57:709-715.
23. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, et al. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959.
24. Towbin H, Staehelin T, Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
25. Woo JS, Jeong JY, Hwang YJ, Chae SW, Hwang SJ, Lee HM (2003). Expression of cathelicidin in human salivary glands. Arch Otolaryngol Head Neck Surg 129:211-214.
26. Zasloff M (2002a). Innate immunity, antimicrobial peptides, and protection of the oral cavity. Lancet 360:1116-1117.
27. Zasloff M (2002b). Antimicrobial peptides of multicellular organisms. Nature 415:389-395.